カテゴリー： 世界, 医療/バイオ, MarketsandMarkets

世界の眼科機器市場（～2029年）：機器別（外科（膜硝子体、IOL、OVD、コンタクトレンズ、RGPレンズ、バックフラッシュ）、診断・モニタリング（OCT、オートレフラクター、角膜計、眼圧計、検眼鏡、OVD））、エンドユーザー別

【英語タイトル】Ophthalmic Equipment Market by Devices (Surgical: Vitreoretinal, IOLs, OVDs, Contact Lens, RGP Lens, Backflush; Diagnostic & Monitoring: OCT, Autorefractor, Keratometer, Tonometer, Ophthalmoscope, OVD), End User, Buying Criteria - Global Forecast to 2029

MarketsandMarketsが出版した調査資料（MD2334-24）・商品コード：MD2334-24
・発行会社（調査会社）：MarketsandMarkets
・発行日：2024年1月15日
・ページ数：459
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD7,150 ⇒換算￥1,086,800見積依頼/購入/質問フォーム
Multi User (Five User)USD8,500 ⇒換算￥1,292,000見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD9,650 ⇒換算￥1,466,800見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

“眼科機器市場は2023年に推定662億米ドルと評価され、予測期間中のCAGRは4.9％で、2029年には885億米ドルに達すると予測”眼科機器市場は、主に高齢化による眼疾患の増加、高齢者人口の増加、携帯電話やコンピュータ画面からの放射線被曝、新興国における意識の高まり、患者訪問の増加による設備の整った診療所や病院の増加、遺伝性の影響を受けています。

“眼科機器市場で最大のシェアを占める網膜鏡セグメント”
網膜鏡は、診断・モニタリングセグメントの眼科用超音波機器のサブセグメントに属するものです。その大きなシェアは、自動補正、屈折異常測定の正確さ、非侵襲的な手順、手術中のリスクの最小化など、客観的測定のような従来のツールよりも優れていることに起因しています。例えば、白内障手術では、屈折異常の正確な知識は、正しい眼内レンズ移植を選択するために不可欠です。同様に、レーシックやPRKなどの屈折矯正手術では、屈折異常を正確に矯正するためのレーザーのガイドとして網膜鏡検査が使用されます。そのため、この分野では大きなシェアを占めています。

“緑内障手術機器は眼科手術機器市場で最も高い成長率が見込まれる”
緑内障手術は、主に新興国における老人人口の増加により増加傾向にあります。視力を奪うこの病気のリスクは、40歳を過ぎると著しく高まります。これは、自然な老化プロセスと、糖尿病や肥満のような不健康な生活習慣の増加によるものです。このような人口動態の変化は憂慮すべき事態ですが、明るい兆しがないわけではありません。診断技術の進歩や人々の意識の高まりにより、これまで隠れていた症例が明るみに出てきています。また、遺伝子治療や幹細胞治療に関する画期的な研究により、将来的な治療の道筋が見えてきています。しかし、緑内障による視力喪失との闘いにおいては、特に十分な医療を受けられない地域社会で、安価な眼科医療への公平なアクセスを確保することが最も重要であることに変わりはありません。早期発見と迅速な介入は、この急成長する戦いにおける最も強力な武器であり、視力を維持し、黄昏時だけでなく、人間のあらゆる経験にわたって生活の質を維持するために極めて重要です。

“予測期間中、アジア太平洋市場が最も高い成長を遂げる”
予測期間中、アジア太平洋は最も速い速度で成長すると予測されています。この地域の眼科機器市場の成長を促進する主な要因は、若年層から眼科クリニックや病院を訪れるようになること、新興国における高齢者人口の増加、健康診断の改善に対する意識の高まり、糖尿病網膜症を引き起こす糖尿病のような基礎疾患などに関する認識です。

本レポートで参照した眼科機器市場の主要参入企業（供給側）の内訳は以下の通りです：

- 企業タイプ別 ティア1：60％、ティア2：30％、ティア3：10％
- 役職別 Cレベルエグゼクティブ 30％、取締役 50％、その他：20％
- 地域別 北米：45％、ヨーロッパ：15％、アジア太平洋：25％、中南米：10％、中東・アフリカ：5％

眼科機器市場に参入している主な企業は、Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson & Johnson (US), Hoya Corporation (Japan), The Cooper Companies, Inc.(US), EssilorLuxottica (France), Canon Inc. (Japan), Glaukos Corporation (US), Nidek Co., Ltd. (Japan), Topcon Corporation (Japan), Ziemer Ophthalmic Systems (Switzerland), Staar Surgical (US), Haag-Streit (Switzerland), Quantel Medical (US), Coburn Technologies, Inc. (US), FCI Ophthalmics (US), Matronix India Corporation (India), HEINE Optotechnik (Germany), Visionix (France), Neo Vision (Korea), Clear Lab (Singapore), BVI (US), DORC (Netherlands), CORZA Medical (US), Appasamy Associates (India), Ophtec BV (Netherlands), Lumenis (Israel), and Intuvision Labs (India)です。

調査対象範囲

この調査レポートは、様々なセグメントにわたる眼科機器市場を対象としています。製品別、エンドユーザー別、地域別など、さまざまなセグメントにおける市場規模や成長可能性を推定することを目的としています。また、市場主要企業の詳細な競合分析、企業プロフィール、製品および事業内容、最近の動向、主要な市場戦略に関する主な見解も掲載しています。

レポート購入の理由

本レポートは、眼科機器市場全体およびサブセグメントにおける収益数の最も近い近似値に関する情報を提供することで、本市場における市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、自社のビジネスをより良く位置づけ、適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、本レポートは、関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します：

- 主要促進要因（高齢者人口の増加、眼疾患の有病率の上昇、眼科機器の技術進歩、視覚障害を制御するための政府イニシアチブの増加、コンタクトレンズと眼鏡の採用率の上昇）、阻害要因（眼科手術に関連する高コストとリスク、眼科機器のコスト上昇、 眼科機器市場の成長に影響を与える機会（新興市場における潜在的成長機会、新興地域における超音波乳化吸引装置と高級眼内レンズの低い採用率）、課題（低所得国における眼科医療へのアクセスの低さ、熟練した専門家の不足）の分析しました。
- 市場への浸透： 眼科機器診断市場のトップ企業が提供する製品ポートフォリオに関する包括的な情報を記載しています。製品タイプ別、エンドユーザー別、地域別に市場を分析しています。
- 製品の強化/革新： 眼科機器診断市場における今後の動向と製品発売に関する詳細な洞察を提供します。
- 市場開発： 製品タイプ、用途、技術、動物種、流通チャネル、エンドユーザー、地域別に、有利な新興市場に関する包括的情報を記載しています。
- 市場の多様化： 眼科機器診断市場における新製品とサービス、成長地域、最近の開発、投資に関する詳細な情報を記載しています。
- 競合評価： 眼科機器診断市場における主要企業の市場シェア、成長戦略、製品・サービス提供、能力を詳細に評価します。

1.　序論
2.　調査方法
3.　エグゼクティブサマリー
4.　プレミアムインサイト
5.　市場概要
6.　世界の眼科機器市場規模：製品別
7.　世界の眼科機器市場規模：エンドユーザー別
8.　世界の眼科機器市場規模：地域別
9.　競争状況
10.　企業情報
11.　付録

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 INTRODUCTION 51
1.1 STUDY OBJECTIVES 51
1.2 MARKET DEFINITION AND SCOPE 51
1.2.1 INCLUSIONS & EXCLUSIONS 52
1.3 MARKET SCOPE 53
1.3.1 MARKETS COVERED 53
FIGURE 1 OPHTHALMIC EQUIPMENT MARKET SEGMENTATION 53
1.3.2 REGIONAL SCOPE 54
FIGURE 2 OPHTHALMIC EQUIPMENT MARKET: REGIONAL SEGMENTATION 54
1.3.3 YEARS CONSIDERED 54
1.4 CURRENCY 55
TABLE 1 USD EXCHANGE RATES 55
1.5 STAKEHOLDERS 55
1.6 SUMMARY OF CHANGES 56
1.7 RECESSION IMPACT 56
2 RESEARCH METHODOLOGY 57
2.1 RESEARCH DATA 57
FIGURE 3 RESEARCH DESIGN 57
2.1.1 SECONDARY DATA 57
2.1.1.1 Key data from secondary sources 58
2.1.2 PRIMARY DATA 59
FIGURE 4 PRIMARY SOURCES 59
2.1.2.1 Key data from primary sources 60
2.1.2.2 Key industry insights 61
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 61
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS 62
2.2 MARKET SIZE ESTIMATION 62
FIGURE 7 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 63
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: BAUSCH HEALTH 63
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: OPHTHALMIC EQUIPMENT MARKET (2022) 64
FIGURE 10 BOTTOM-UP APPROACH: VISION CARE PRODUCTS COMPANY REVENUE ESTIMATION APPROACH 65
FIGURE 11 BOTTOM-UP APPROACH: SURGICAL DEVICES COMPANY REVENUE ESTIMATION APPROACH 65
FIGURE 12 BOTTOM-UP APPROACH: OPHTHALMIC DIAGNOSTIC & MONITORING EQUIPMENT COMPANY REVENUE ESTIMATION APPROACH 66
2.2.1 CAGR PROJECTIONS 67
FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 67
2.2.2 TOP-DOWN APPROACH 67
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN OPHTHALMIC EQUIPMENT MARKET (2022–2027): IMPACT ON GROWTH & CAGR 68
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 69
FIGURE 15 DATA TRIANGULATION METHODOLOGY 69
2.4 MARKET SHARE ANALYSIS 69
2.5 STUDY ASSUMPTIONS 70
2.6 LIMITATIONS 70
2.6.1 METHODOLOGY-RELATED LIMITATIONS 70
2.6.2 SCOPE-RELATED LIMITATIONS 70
2.7 RISK ASSESSMENT 71
TABLE 2 RISK ASSESSMENT: OPHTHALMIC EQUIPMENT MARKET 71
2.8 RECESSION IMPACT ANALYSIS 71
3 EXECUTIVE SUMMARY 72
FIGURE 16 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023 VS. 2029 (USD MILLION) 72
FIGURE 17 OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2023 VS. 2029 (USD MILLION) 73
FIGURE 18 OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023 VS. 2029 (USD MILLION) 74
FIGURE 19 OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023 VS. 2029 (USD MILLION) 75
FIGURE 20 OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023 VS. 2029 (USD MILLION) 76
FIGURE 21 REGIONAL SNAPSHOT OF OPHTHALMIC EQUIPMENT MARKET 77
4 PREMIUM INSIGHTS 78
4.1 OPHTHALMIC EQUIPMENT MARKET OVERVIEW 78
FIGURE 22 RISING PREVALENCE OF EYE DISEASES TO DRIVE MARKET GROWTH 78
4.2 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY AND END USER (2022) 79
FIGURE 23 CONSUMERS ACCOUNTED DOMINATED NORTH AMERICAN OPHTHALMIC EQUIPMENT MARKET IN 2022 79
4.3 OPHTHALMIC EQUIPMENT MARKET: REGIONAL GROWTH OPPORTUNITIES 80
FIGURE 24 INDIA TO REGISTER HIGHEST GROWTH RATE FROM 2023 TO 2029 80
4.4 OPHTHALMIC EQUIPMENT MARKET, BY REGION (2023─2029) 81
FIGURE 25 NORTH AMERICA TO LEAD MARKET UNTIL 2029 81
4.5 OPHTHALMIC EQUIPMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS 81
FIGURE 26 DEVELOPING MARKETS TO REGISTER FASTER GROWTH DURING FORECAST PERIOD 81
5 MARKET OVERVIEW 82
5.1 INTRODUCTION 82
5.2 MARKET DYNAMICS 82
FIGURE 27 OPHTHALMIC EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 82
5.2.1 DRIVERS 83
5.2.1.1 Increasing geriatric population 83
TABLE 3 INCREASE IN GERIATRIC POPULATION, 2000–2050 83
5.2.1.2 Rising prevalence of eye disorders 83
TABLE 4 GLOBAL PREVALENCE OF EYE DISORDERS, BY TYPE, 2022 (IN MILLION) 84
5.2.1.2.1 Cataracts 84
TABLE 5 NUMBER OF CATARACT SURGERIES, BY COUNTRY (2020 VS. 2021) 84
5.2.1.2.2 Glaucoma 85
TABLE 6 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2020 VS. 2040 (MILLION) 85
5.2.1.2.3 Obesity and diabetes 85
TABLE 7 NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2030 VS. 2045 (MILLION) 86
5.2.1.2.4 Age-related macular degeneration (AMD) 86
TABLE 8 NUMBER OF PEOPLE WITH AGE-RELATED MACULAR DEGENERATION, BY REGION, 2020 VS. 2050 (MILLION) 86
5.2.1.3 Technological advancements in ophthalmic devices 87
TABLE 9 RECENT PRODUCT LAUNCHES IN OPHTHALMIC EQUIPMENT MARKET (2020–2022) 87
5.2.1.4 Increased government initiatives to control visual impairment 87
5.2.1.5 Rising adoption of contact lenses and spectacles 88
TABLE 10 PREVALENCE AND PATIENT POPULATION FOR MYOPIA, 2020–2050 88
5.2.2 RESTRAINTS 89
5.2.2.1 High cost and risk associated with eye surgeries 89
5.2.2.2 High cost of ophthalmology devices 89
TABLE 11 PRICE OF OPHTHALMIC EQUIPMENT, BY TYPE (2022) 90
5.2.2.3 Rising adoption of refurbished ophthalmic devices 90
5.2.3 OPPORTUNITIES 91
5.2.3.1 Potential growth opportunities in emerging markets 91
5.2.3.2 Low adoption of phacoemulsification devices and premium IOLs in emerging markets 91
5.2.4 CHALLENGES 92
5.2.4.1 Low accessibility to eye care in low-income countries 92
5.2.4.2 Lack of skilled professionals 92
5.3 TECHNOLOGY ANALYSIS 93
5.4 INDUSTRY TRENDS 94
5.4.1 INNOVATIVE APPLICATION OF FEMTOSECOND LASER TECHNOLOGY 94
5.4.2 MINIMALLY INVASIVE GLAUCOMA SURGERY 94
5.5 PRICING ANALYSIS 95
TABLE 12 REGIONAL PRICING ANALYSIS OF OPHTHALMIC EQUIPMENT, 2022 (USD) 95
5.5.1 VISION CARE PRODUCTS PRICING ANALYSIS, BY KEY PLAYER 95
TABLE 13 VISION CARE PRODUCTS PRICING ANALYSIS, BY KEY PLAYER, 2022 (USD) 95
5.5.2 SURGICAL DEVICES PRICING ANALYSIS, BY KEY PLAYER 96
TABLE 14 SURGICAL DEVICES PRICING ANALYSIS, BY KEY PLAYER, 2022 (USD) 96
5.5.3 DIAGNOSTIC & MONITORING DEVICES PRICING ANALYSIS, BY KEY PLAYERS 96
TABLE 15 DIAGNOSTIC & MONITORING DEVICES PRICING ANALYSIS, BY KEY PLAYER, 2022 (USD) 96
5.6 VALUE CHAIN ANALYSIS 97
FIGURE 28 OPHTHALMIC EQUIPMENT MARKET: VALUE CHAIN ANALYSIS 97
5.7 SUPPLY CHAIN ANALYSIS 98
FIGURE 29 OPHTHALMIC EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS 98
5.8 ECOSYSTEM ANALYSIS 99
FIGURE 30 OPHTHALMIC EQUIPMENT MARKET: ECOSYSTEM MAPPING 99
TABLE 16 OPHTHALMIC EQUIPMENT MARKET: ROLE IN ECOSYSTEM 100
5.9 TARIFF AND REGULATORY LANDSCAPE 100
5.9.1 REGULATORY ANALYSIS 100
5.9.2 NORTH AMERICA 100
5.9.2.1 US 100
5.9.2.2 Canada 101
5.9.3 EUROPE 101
5.9.4 ASIA PACIFIC 101
5.9.4.1 China 101
5.9.4.2 Japan 102
5.9.4.3 India 102
5.9.5 LATIN AMERICA 102
5.9.5.1 Brazil 102
5.9.5.2 Mexico 103
5.9.6 MIDDLE EAST 103
5.9.7 AFRICA 103
5.10 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
5.11 PORTER’S FIVE FORCES ANALYSIS 105
TABLE 21 OPHTHALMIC EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 105
5.11.1 THREAT OF NEW ENTRANTS 105
5.11.2 THREAT OF SUBSTITUTES 105
5.11.3 BARGAINING POWER OF BUYERS 106
5.11.4 BARGAINING POWER OF SUPPLIERS 106
5.11.5 INTENSITY OF COMPETITIVE RIVALRY 106
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 106
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 106
FIGURE 31 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF OPHTHALMIC EQUIPMENT PRODUCTS 106
TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF OPHTHALMIC EQUIPMENT PRODUCTS 107
5.12.2 BUYING CRITERIA 107
FIGURE 32 KEY BUYING CRITERIA FOR OPHTHALMIC EQUIPMENT PRODUCTS 107
TABLE 23 KEY BUYING CRITERIA FOR OPHTHALMIC EQUIPMENT PRODUCTS 107
5.13 KEY CONFERENCES AND EVENTS IN 2023-2024 108
TABLE 24 OPHTHALMIC EQUIPMENT MARKET: CONFERENCES AND EVENTS 108
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES 109
5.14.1 REVENUE SOURCES TO SHIFT TOWARD TECHNOLOGICALLY ADVANCED OPHTHALMIC EQUIPMENT 109
FIGURE 33 REVENUE SHIFT IN OPHTHALMIC EQUIPMENT MARKET 109
5.15 TRADE ANALYSIS 110
5.15.1 TRADE ANALYSIS FOR OPHTHALMIC EQUIPMENT PRODUCTS 110
TABLE 25 IMPORT DATA FOR ARTICLES AND EQUIPMENT FOR OPHTHALMIC PRODUCTS, BY COUNTRY, 2017–2021 (USD MILLION) 110
TABLE 26 EXPORT DATA FOR ARTICLES AND EQUIPMENT FOR OPHTHALMIC PRODUCTS, BY COUNTRY, 2017–2021 (USD MILLION) 110
5.16 PATENT ANALYSIS 111
5.16.1 PATENT PUBLICATION TRENDS FOR OPHTHALMIC EQUIPMENT 111
FIGURE 34 PATENT PUBLICATION TRENDS IN OPHTHALMIC EQUIPMENT MARKET, 2013–2023 111
5.16.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 111
FIGURE 35 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR OPHTHALMIC EQUIPMENT PATENTS (JANUARY 2013–NOVEMBER 2023) 112
FIGURE 36 TOP APPLICANT COUNTRIES/REGIONS FOR OPHTHALMIC EQUIPMENT (JANUARY 2013–NOVEMBER 2023) 112
TABLE 27 LIST OF MAJOR PATENTS/PATENT APPLICATIONS IN OPHTHALMIC EQUIPMENT MARKET 113
5.17 CASE STUDY 114
5.18 ADJACENT MARKETS 115
5.19 ARTIFICIAL INTELLIGENCE (AI) IN OPHTHALMIC EQUIPMENT 115
5.20 UNMET NEEDS/END USER EXPECTATIONS IN OPHTHALMIC EQUIPMENT 116
6 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT 117
6.1 INTRODUCTION 118
TABLE 28 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 118
6.2 VISION CARE PRODUCTS 118
TABLE 29 VISION CARE PRODUCTS OFFERED BY KEY PLAYERS 119
TABLE 30 VISION CARE PRODUCTS: OPHTHALMIC EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 120
TABLE 31 VISION CARE PRODUCTS: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 121
6.2.1 SPECTACLES 122
6.2.1.1 Rising adoption of digital devices to drive market 122
TABLE 32 SPECTACLES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 123
6.2.2 CONTACT LENSES 123
6.2.2.1 Increasing prevalence of vision disorders to increase demand 123
TABLE 33 CONTACT LENSES OFFERED BY KEY MARKET PLAYERS 124
TABLE 34 CONTACT LENSES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 125
6.3 SURGICAL DEVICES 126
TABLE 35 SURGICAL DEVICES: OPHTHALMIC EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 126
TABLE 36 SURGICAL DEVICES: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 127
6.3.1 CATARACT SURGICAL DEVICES 127
TABLE 37 CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 128
TABLE 38 CATARACT SURGICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 129
6.3.1.1 Ophthalmic viscoelastic devices 129
6.3.1.1.1 Increasing number of cataract surgeries to support market growth 129
TABLE 39 OPHTHALMIC VISCOELASTIC DEVICES OFFERED BY KEY MARKET PLAYERS 130
TABLE 40 OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 131
6.3.1.2 Phacoemulsification devices 131
6.3.1.2.1 Advancements in phacoemulsification devices to increase demand during forecast period 131
TABLE 41 PHACOEMULSIFICATION OFFERED BY KEY MARKET PLAYERS 132
TABLE 42 PHACOEMULSIFICATION DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 133
6.3.1.3 Cataract surgical lasers 133
TABLE 43 CATARACT SURGICAL LASERS OFFERED BY KEY MARKET PLAYERS 134
TABLE 44 CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 135
TABLE 45 CATARACT SURGICAL LASERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 135
6.3.1.3.1 Femtosecond lasers 136
TABLE 46 FEMTOSECOND LASERS OFFERED BY KEY MARKET PLAYERS 136
TABLE 47 FEMTOSECOND LASERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 137
6.3.1.3.2 Nd-YAG lasers 137
TABLE 48 ND-YAG LASERS OFFERED BY KEY MARKET PLAYERS 138
TABLE 49 ND-YAG LASERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 138
6.3.1.3.3 Other lasers 139
TABLE 50 OTHER LASERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 139
6.3.1.4 IOL injectors 140
6.3.1.4.1 Rising need for accurate implantation of IOLs to boost market growth 140
TABLE 51 IOL INJECTORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 140
TABLE 52 IOL INJECTORS OFFERED BY KEY PLAYERS 141
6.3.1.5 Intraocular lenses 141
6.3.1.5.1 Rising prevalence of cataracts globally to propel segment 141
TABLE 53 INTRAOCULAR LENSES OFFERED BY KEY PLAYERS 142
TABLE 54 INTRAOCULAR LENSES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 143
6.3.2 VITREORETINAL SURGICAL DEVICES 143
TABLE 55 VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 144
TABLE 56 VITREORETINAL SURGICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 145
6.3.2.1 Vitrectomy machines 146
6.3.2.1.1 Vitrectomy machines widely used to correct retinal errors 146
TABLE 57 VITRECTOMY MACHINES OFFERED BY KEY MARKET PLAYERS 146
TABLE 58 VITRECTOMY MACHINES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 147
6.3.2.2 Vitreoretinal packs 147
6.3.2.2.1 Increasing awareness about vitreoretinal surgery to increase utilization of vitreoretinal packs 147
TABLE 59 VITREORETINAL PACKS OFFERED BY KEY MARKET PLAYERS 148
TABLE 60 VITREORETINAL PACKS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 148
6.3.2.3 Photocoagulation lasers 149
6.3.2.3.1 Rising prevalence of various eye diseases to drive market growth 149
TABLE 61 PHOTOCOAGULATION LASERS OFFERED BY KEY MARKET PLAYERS 149
TABLE 62 PHOTOCOAGULATION LASERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 150
6.3.2.4 Illumination devices 150
6.3.2.4.1 Portable, powerful illuminators widely used for greater efficiency 150
TABLE 63 ILLUMINATION DEVICES OFFERED BY KEY MARKET PLAYERS 151
TABLE 64 ILLUMINATION DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 152
6.3.2.5 Vitrectomy probes 152
6.3.2.5.1 Advancements in vitrectomy probes provide rapid cutting speed to remove vitreous bodies 152
TABLE 65 VITRECTOMY PROBES OFFERED BY KEY MARKET PLAYERS 153
TABLE 66 VITRECTOMY PROBES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 153
6.3.2.6 Backflushes 154
6.3.2.6.1 Backflushes used to prevent damage or complications to eye structure 154
TABLE 67 BACKFLUSHES OFFERED BY KEY MARKET PLAYERS 154
TABLE 68 BACKFLUSHES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 155
6.3.2.7 Chandeliers 155
6.3.2.7.1 Use of chandeliers offers improved visualization of retina 155
TABLE 69 CHANDELIERS OFFERED BY KEY MARKET PLAYERS 156
TABLE 70 CHANDELIERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 156
6.3.3 REFRACTIVE SURGICAL DEVICES 157
TABLE 71 REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 157
TABLE 72 REFRACTIVE SURGICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 158
6.3.3.1 Femtosecond lasers 158
6.3.3.1.1 Rising preference for femtosecond lasers over microkeratomes to support market growth 158
TABLE 73 FEMTOSECOND LASERS OFFERED BY KEY MARKET PLAYERS 159
TABLE 74 FEMTOSECOND LASERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 160
6.3.3.2 Excimer lasers 160
6.3.3.2.1 Rising prevalence of myopia to drive market 160
TABLE 75 EXCIMER LASERS OFFERED BY KEY MARKET PLAYERS 161
TABLE 76 EXCIMER LASERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 162
6.3.3.3 Other refractive surgical devices 162
TABLE 77 OTHER REFRACTIVE SURGICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 163
6.3.4 GLAUCOMA SURGICAL DEVICES 163
TABLE 78 GLAUCOMA SURGICAL DEVICES OFFERED BY KEY MARKET PLAYERS 164
TABLE 79 GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 164
TABLE 80 GLAUCOMA SURGICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 165
6.3.4.1 Microinvasive glaucoma surgery devices 165
6.3.4.1.1 Growing preference for microinvasive glaucoma surgery drives adoption 165
TABLE 81 MICROINVASIVE GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 166
6.3.4.2 Glaucoma drainage devices 167
6.3.4.2.1 Rising prevalence of glaucoma across the globe drives market growth 167
TABLE 82 GLAUCOMA DRAINAGE DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 168
6.3.4.3 Glaucoma laser systems 168
6.3.4.3.1 Increasing prevalence of open-angle glaucoma to boost segment 168
TABLE 83 GLAUCOMA LASER SYSTEMS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 169
6.3.5 OPHTHALMIC MICROSCOPES 170
6.3.5.1 Increasing prevalence of eye diseases to drive demand 170
TABLE 84 OPHTHALMIC MICROSCOPES OFFERED BY KEY MARKET PLAYERS 170
TABLE 85 OPHTHALMIC MICROSCOPES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 171
6.3.6 OPHTHALMIC SURGICAL ACCESSORIES 171
TABLE 86 OPHTHALMIC SURGICAL ACCESSORIES OFFERED BY KEY MARKET PLAYERS 172
TABLE 87 OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY TYPE, 2021–2029 (USD MILLION) 173
TABLE 88 OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 174
6.3.6.1 Surgical instruments & kits 174
6.3.6.1.1 Surgical instruments & kits hold largest share of accessories market 174
TABLE 89 SURGICAL INSTRUMENTS & KITS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 175
6.3.6.2 Ophthalmic tips & handles 176
6.3.6.2.1 Wide range of tips and handles available to meet end user demand 176
TABLE 90 OPHTHALMIC TIPS & HANDLES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 176
6.3.6.3 Ophthalmic scissors 177
6.3.6.3.1 End user preference skewed toward titanium scissors 177
TABLE 91 OPHTHALMIC SCISSORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 177
6.3.6.4 Ophthalmic forceps 178
6.3.6.4.1 Forceps find wide use in ophthalmological surgeries 178
TABLE 92 OPHTHALMIC FORCEPS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 178
6.3.6.5 Ophthalmic spatulas 179
6.3.6.5.1 China to be fastest-growing market for ophthalmic spatulas 179
TABLE 93 OPHTHALMIC SPATULAS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 179
6.3.6.6 Macular lenses 180
6.3.6.6.1 Rise in adoption of macular lenses witnessed for hands-free operation 180
TABLE 94 MACULAR LENSES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 180
6.3.6.7 Ophthalmic cannulas 181
6.3.6.7.1 Rising adoption of single-use cannulas to drive market growth 181
TABLE 95 OPHTHALMIC CANNULAS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 181
6.3.6.8 Other ophthalmic surgical accessories 182
TABLE 96 OTHER OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 182
6.4 DIAGNOSTIC & MONITORING DEVICES 183
TABLE 97 DIAGNOSTIC & MONITORING DEVICES: OPHTHALMIC EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 184
TABLE 98 DIAGNOSTIC & MONITORING DEVICES: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 185
6.4.1 OPTICAL COHERENCE TOMOGRAPHY SCANNERS 185
6.4.1.1 High-depth image analysis obtained in real time 185
TABLE 99 OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 187
TABLE 100 OCT SCANNERS OFFERED BY KEY MARKET PLAYERS 188
6.4.2 FUNDUS CAMERAS 188
6.4.2.1 Rising prevalence of age-related disorders to boost segment 188
TABLE 101 FUNDUS CAMERAS OFFERED BY KEY MARKET PLAYERS 189
TABLE 102 FUNDUS CAMERAS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 190
6.4.3 PERIMETERS/VISUAL FIELD ANALYZERS 190
6.4.3.1 Increasing incidence of glaucoma and AMD drive demand for perimeters 190
TABLE 103 PERIMETERS/VISUAL FIELD ANALYZERS OFFERED BY KEY MARKET PLAYERS 191
TABLE 104 PERIMETERS/VISUAL FIELD ANALYZERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 192
6.4.4 AUTOREFRACTORS & KERATOMETERS 192
6.4.4.1 Rising patient population with visual impairment to drive utilization 192
TABLE 105 AUTOREFRACTORS & KERATOMETERS OFFERED BY KEY MARKET PLAYERS 193
TABLE 106 AUTOREFRACTORS & KERATOMETERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 194
6.4.5 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 194
TABLE 107 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2021–2029 (USD MILLION) 195
TABLE 108 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 196
6.4.5.1 A-scan ultrasound imaging systems 196
6.4.5.1.1 Most widely used to measure length of eye in common eye disorders 196
TABLE 109 OPHTHALMIC A-SCAN ULTRASOUND IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS 197
TABLE 110 OPHTHALMIC A-SCAN ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 198
6.4.5.2 B-scan ultrasound imaging systems 198
6.4.5.2.1 B-scans assess eye and orbit to determine eye disorders 198
TABLE 111 OPHTHALMIC B-SCAN ULTRASOUND IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS 199
TABLE 112 OPHTHALMIC B-SCAN ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 199
6.4.5.3 Ultrasound biomicroscopes 200
6.4.5.3.1 Rising volume of refractive surgeries fuels market growth 200
TABLE 113 OPHTHALMIC ULTRASOUND BIOMICROSCOPES OFFERED BY KEY MARKET PLAYERS 200
TABLE 114 OPHTHALMIC ULTRASOUND BIOMICROSCOPES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 201
6.4.5.4 Pachymeters 201
6.4.5.4.1 Ophthalmic pachymeters widely used to monitor condition of cornea 201
TABLE 115 OPHTHALMIC PACHYMETERS OFFERED BY KEY MARKET PLAYERS 202
TABLE 116 OPHTHALMIC PACHYMETERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 203
6.4.6 TONOMETERS 203
6.4.6.1 Rising prevalence of glaucoma to boost demand 203
TABLE 117 TONOMETERS OFFERED BY KEY MARKET PLAYERS 204
TABLE 118 TONOMETERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 205
6.4.7 SLIT LAMPS 205
6.4.7.1 Rising prevalence of ocular conditions to drive market 205
TABLE 119 SLIT LAMPS OFFERED BY KEY MARKET PLAYERS 206
TABLE 120 SLIT LAMPS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 207
6.4.8 PHOROPTERS 207
6.4.8.1 Phoropters aid in measurement of refractive errors 207
TABLE 121 PHOROPTERS OFFERED BY KEY MARKET PLAYERS 208
TABLE 122 PHOROPTERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 209
6.4.9 WAVEFRONT ABERROMETERS 209
6.4.9.1 Aberrometers – highly effective in measuring refractive aberrations 209
TABLE 123 WAVEFRONT ABERROMETERS OFFERED BY KEY MARKET PLAYERS 210
TABLE 124 WAVEFRONT ABERROMETERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 210
6.4.10 OPTICAL BIOMETRY SYSTEMS 211
6.4.10.1 Advantages of optical biometry systems boost adoption in diagnostics 211
TABLE 125 OPTICAL BIOMETRY SYSTEMS OFFERED BY KEY MARKET PLAYERS 211
TABLE 126 OPTICAL BIOMETRY SYSTEMS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 212
6.4.11 OPHTHALMOSCOPES 212
6.4.11.1 Increasing number of patients with glaucoma, diabetic retinopathy, and AMD fuels market 212
TABLE 127 OPHTHALMOSCOPES OFFERED BY KEY MARKET PLAYERS 213
TABLE 128 OPHTHALMOSCOPES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 214
6.4.12 LENSMETERS 214
6.4.12.1 Rising prevalence of myopia & hyperopia – key drivers 214
TABLE 129 LENSMETERS OFFERED BY KEY MARKET PLAYERS 215
TABLE 130 LENSMETERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 216
6.4.13 CORNEAL TOPOGRAPHY SYSTEMS 216
6.4.13.1 Increasing number of LASIK procedures drives demand 216
TABLE 131 CORNEAL TOPOGRAPHY SYSTEMS OFFERED BY KEY MARKET PLAYERS 217
TABLE 132 CORNEAL TOPOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 217
6.4.14 CHART PROJECTORS 218
6.4.14.1 Provide practitioners access to multiple chart types in one device 218
TABLE 133 CHART PROJECTORS OFFERED BY KEY MARKET PLAYERS 218
TABLE 134 CHART PROJECTORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 219
6.4.15 SPECULAR MICROSCOPES 219
6.4.15.1 Growing number of patients with diabetes to drive market 219
TABLE 135 SPECULAR MICROSCOPES OFFERED BY KEY MARKET PLAYERS 220
TABLE 136 SPECULAR MICROSCOPES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 220
6.4.16 RETINOSCOPES 221
6.4.16.1 Rising prevalence of myopia across the globe boosts market growth 221
TABLE 137 RETINOSCOPES OFFERED BY KEY MARKET PLAYERS 221
TABLE 138 RETINOSCOPES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 222
7 OPHTHALMIC EQUIPMENT MARKET, BY END USER 223
7.1 INTRODUCTION 224
TABLE 139 OPHTHALMIC EQUIPMENT MARKET BY END USER, 2021–2029 (USD MILLION) 224
7.2 CONSUMERS 224
7.2.1 RISING PREVALENCE OF OCULAR DISORDERS AND ADOPTION OF CONTACT LENSES AND SPECTACLES DRIVE MARKET GROWTH 224
TABLE 140 CONSUMERS: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 225
7.3 HOSPITALS 226
7.3.1 LARGE PATIENT POOL AND HIGH PURCHASING POWER OF HOSPITALS TO DRIVE GROWTH 226
TABLE 141 HOSPITALS: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 227
7.4 SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS 228
7.4.1 COST-EFFECTIVENESS OF AMBULATORY CARE TO ENHANCE END USER INTEREST 228
FIGURE 37 US: NUMBER OF AMBULATORY SURGICAL CENTERS (2012–2022) 229
TABLE 142 SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 230
7.5 OTHER END USERS 230
TABLE 143 OTHER END USERS: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 231
8 OPHTHALMIC EQUIPMENT MARKET, BY REGION 232
8.1 INTRODUCTION 233
FIGURE 38 OPHTHALMIC EQUIPMENT MARKET: REGIONAL GROWTH OPPORTUNITIES 233
8.2 NORTH AMERICA 234
8.2.1 NORTH AMERICA: RECESSION IMPACT 234
FIGURE 39 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET SNAPSHOT 235
TABLE 144 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 236
TABLE 145 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 236
TABLE 146 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 237
TABLE 147 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 238
TABLE 148 NORTH AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 238
TABLE 149 NORTH AMERICA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 239
TABLE 150 NORTH AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 239
TABLE 151 NORTH AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 239
TABLE 152 NORTH AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 240
TABLE 153 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 240
TABLE 154 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 241
8.2.2 US 241
8.2.2.1 Rising geriatric population and increasing healthcare expenditure to drive market 241
TABLE 155 US: KEY MACROINDICATORS 242
TABLE 156 US: NUMBER OF OCULAR CONDITIONS, 2000–2020 (MILLION) 242
TABLE 157 US: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 242
TABLE 158 US: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 243
TABLE 159 US: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 244
TABLE 160 US: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 244
TABLE 161 US: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 245
TABLE 162 US: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 245
TABLE 163 US: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 245
TABLE 164 US: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 246
TABLE 165 US: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 246
TABLE 166 US: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 247
8.2.3 CANADA 247
8.2.3.1 Rising awareness about eye care and increasing ocular diseases to drive market 247
TABLE 167 CANADA: KEY MACROINDICATORS 248
TABLE 168 CANADA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 248
TABLE 169 CANADA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 249
TABLE 170 CANADA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 250
TABLE 171 CANADA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 250
TABLE 172 CANADA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 251
TABLE 173 CANADA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 251
TABLE 174 CANADA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 251
TABLE 175 CANADA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 252
TABLE 176 CANADA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 252
TABLE 177 CANADA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 253

8.3 EUROPE 253
8.3.1 EUROPE: RECESSION IMPACT 253
TABLE 178 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 254
TABLE 179 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 254
TABLE 180 EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 255
TABLE 181 EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 256
TABLE 182 EUROPE: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 256
TABLE 183 EUROPE: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 257
TABLE 184 EUROPE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 257
TABLE 185 EUROPE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 257
TABLE 186 EUROPE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 258
TABLE 187 EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 258
TABLE 188 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 259
8.3.2 GERMANY 259
8.3.2.1 Increasing healthcare expenditure to boost market 259
TABLE 189 GERMANY: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 260
TABLE 190 GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 260
TABLE 191 GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 261
TABLE 192 GERMANY: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 261
TABLE 193 GERMANY: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 262
TABLE 194 GERMANY: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 262
TABLE 195 GERMANY: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 262
TABLE 196 GERMANY: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 263
TABLE 197 GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 263
TABLE 198 GERMANY: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 264
8.3.3 UK 264
8.3.3.1 Rising prevalence of diabetes-related eye diseases to drive market 264
TABLE 199 UK: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 265
TABLE 200 UK: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 265
TABLE 201 UK: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 266
TABLE 202 UK: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 266
TABLE 203 UK: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 267
TABLE 204 UK: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 267
TABLE 205 UK: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 267
TABLE 206 UK: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 268
TABLE 207 UK: OPHTHALMIC EQUIPMENT MARKET
8.3.6 SPAIN 280
8.3.6.1 Increasing ophthalmic surgical procedures to drive market 280
TABLE 229 SPAIN: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 280
TABLE 230 SPAIN: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 281
TABLE 231 SPAIN: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 282
TABLE 232 SPAIN: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 282
TABLE 233 SPAIN: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 283
TABLE 234 SPAIN: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 283
TABLE 235 SPAIN: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 283
TABLE 236 SPAIN: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 284
TABLE 237 SPAIN: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 284
TABLE 238 SPAIN: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 285
8.3.7 REST OF EUROPE 285
TABLE 239 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 286
TABLE 240 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 287
TABLE 241 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 288
TABLE 242 REST OF EUROPE: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 288
TABLE 243 REST OF EUROPE: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 289
TABLE 244 REST OF EUROPE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 289
TABLE 245 REST OF EUROPE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 289
TABLE 246 REST OF EUROPE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 290
TABLE 247 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 290
TABLE 248 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 291
8.4 ASIA PACIFIC 291
8.4.1 ASIA PACIFIC: RECESSION IMPACT 291
FIGURE 40 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET SNAPSHOT 292
TABLE 249 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 293
TABLE 250 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 293
TABLE 251 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 294
TABLE 252 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 295
TABLE 253 ASIA PACIFIC: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 295
TABLE 254 ASIA PACIFIC: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 296
TABLE 255 ASIA PACIFIC: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 296
TABLE 256 ASIA PACIFIC: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 296
TABLE 257 ASIA PACIFIC: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 297
TABLE 258 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 297
TABLE 259 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 298
8.4.2 CHINA 298
8.4.2.1 Rising prevalence of cataracts to drive market 298
TABLE 260 CHINA: KEY MACROINDICATORS 299
TABLE 261 CHINA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 299
TABLE 262 CHINA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 300
TABLE 263 CHINA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 301
TABLE 264 CHINA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 301
TABLE 265 CHINA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 302
TABLE 266 CHINA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 302
TABLE 267 CHINA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 302
TABLE 268 CHINA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 303
TABLE 269 CHINA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 303
TABLE 270 CHINA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 304
8.4.3 JAPAN 304
8.4.3.1 Strong manufacturing capabilities to propel market 304
TABLE 271 JAPAN: KEY MACROINDICATORS 305
TABLE 272 JAPAN: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 305
TABLE 273 JAPAN: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 306
TABLE 274 JAPAN: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 307
TABLE 275 JAPAN: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 307
TABLE 276 JAPAN: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 308
TABLE 277 JAPAN: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 308
TABLE 278 JAPAN: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 308
TABLE 279 JAPAN: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 309
TABLE 280 JAPAN: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 309
TABLE 281 JAPAN: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 310
8.4.4 INDIA 310
8.4.4.1 Increasing geriatric population and prevalence of eye disorders to support market 310
TABLE 282 INDIA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 311
TABLE 283 INDIA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 312
TABLE 284 INDIA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 313
TABLE 285 INDIA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 313
TABLE 286 INDIA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 314
TABLE 287 INDIA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 314
TABLE 288 INDIA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 314
TABLE 289 INDIA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 315
TABLE 290 INDIA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 315
TABLE 291 INDIA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 316
8.4.5 AUSTRALIA 316
8.4.5.1 Increased cataract surgeries to drive market 316
TABLE 292 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 316
TABLE 293 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 317
TABLE 294 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 318
TABLE 295 AUSTRALIA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 318
TABLE 296 AUSTRALIA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 319
TABLE 297 AUSTRALIA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 319
TABLE 298 AUSTRALIA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 319
TABLE 299 AUSTRALIA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 320
TABLE 300 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 320
TABLE 301 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 321
8.4.6 SOUTH KOREA 321
8.4.6.1 Growing focus on medical tourism to boost market 321
TABLE 302 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 322
TABLE 303 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 323
TABLE 304 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 324
TABLE 305 SOUTH KOREA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 324
TABLE 306 SOUTH KOREA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 325
TABLE 307 SOUTH KOREA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 325
TABLE 308 SOUTH KOREA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 325
TABLE 309 SOUTH KOREA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 326
TABLE 310 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 326
TABLE 311 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 327
8.4.7 REST OF ASIA PACIFIC 327
TABLE 312 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 327
TABLE 313 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 328
TABLE 314 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 329
TABLE 315 REST OF ASIA PACIFIC: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 329
TABLE 316 REST OF ASIA PACIFIC: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 330
TABLE 317 REST OF ASIA PACIFIC: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 330
TABLE 318 REST OF ASIA PACIFIC: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 330
TABLE 319 REST OF ASIA PACIFIC: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 331
TABLE 320 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 331
TABLE 321 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 332
8.5 LATIN AMERICA 332
8.5.1 LATIN AMERICA: RECESSION IMPACT 332
TABLE 322 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 333
TABLE 323 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 333
TABLE 324 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 334
TABLE 325 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 335
TABLE 326 LATIN AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 335
TABLE 327 LATIN AMERICA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 336
TABLE 328 LATIN AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 336
TABLE 329 LATIN AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 336
TABLE 330 LATIN AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 337
TABLE 331 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 337
TABLE 332 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 338
8.5.2 BRAZIL 338
8.5.2.1 Government support and initiatives to boost market 338
TABLE 333 BRAZIL: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 339
TABLE 334 BRAZIL: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 340
TABLE 335 BRAZIL: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 341
TABLE 336 BRAZIL: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 341
TABLE 337 BRAZIL: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 342
TABLE 338 BRAZIL: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 342
TABLE 339 BRAZIL: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 342
TABLE 340 BRAZIL: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 343
TABLE 341 BRAZIL: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 343
TABLE 342 BRAZIL: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 344
8.5.3 MEXICO 344
8.5.3.1 Growing incidence of eye disorders to drive market 344
TABLE 343 MEXICO: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 345
TABLE 344 MEXICO: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 345
TABLE 345 MEXICO: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 346
TABLE 346 MEXICO: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 346
TABLE 347 MEXICO: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 347
TABLE 348 MEXICO: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 347
TABLE 349 MEXICO: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 347
TABLE 350 MEXICO: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 348
TABLE 351 MEXICO: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 348
TABLE 352 MEXICO: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 349
8.5.4 ARGENTINA 349
8.5.4.1 Increasing healthcare expenditure and well-developed healthcare system to favor market 349
TABLE 353 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 349
TABLE 354 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 350
TABLE 355 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 351
TABLE 356 ARGENTINA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 351
TABLE 357 ARGENTINA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 352
TABLE 358 ARGENTINA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 352
TABLE 359 ARGENTINA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 352
TABLE 360 ARGENTINA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 353
TABLE 361 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 353
TABLE 362 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 354
8.5.5 REST OF LATIN AMERICA 354
TABLE 363 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 355
TABLE 364 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 356
TABLE 365 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 357
TABLE 366 REST OF LATIN AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 357
TABLE 367 REST OF LATIN AMERICA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 358
TABLE 368 REST OF LATIN AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 358
TABLE 369 REST OF LATIN AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 358
TABLE 370 REST OF LATIN AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 359
TABLE 371 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 359
TABLE 372 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 360
8.6 MIDDLE EAST & AFRICA 360
8.6.1 IMPROVING HEALTHCARE EXPENDITURE TO DRIVE MARKET 360
8.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 361
TABLE 373 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 361
TABLE 374 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 362
TABLE 375 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 363
TABLE 376 MIDDLE EAST & AFRICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 363
TABLE 377 MIDDLE EAST & AFRICA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 364
TABLE 378 MIDDLE EAST & AFRICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 364
TABLE 379 MIDDLE EAST & AFRICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 365
TABLE 380 MIDDLE EAST & AFRICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 365
TABLE 381 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 366
TABLE 382 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 366
9 COMPETITIVE LANDSCAPE 367
9.1 OVERVIEW 367
9.2 KEY STRATEGIES/RIGHT TO WIN 367
FIGURE 41 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN OPHTHALMIC EQUIPMENT MARKET, 2020–2023 368
9.3 REVENUE SHARE ANALYSIS 369
FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS 369
9.4 MARKET SHARE ANALYSIS 370
FIGURE 43 OPHTHALMIC EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2022 370
9.5 COMPETITIVE LEADERSHIP MAPPING: KEY PLAYERS 371
9.5.1 STARS 372
9.5.2 EMERGING LEADERS 372
9.5.3 PERVASIVE PLAYERS 372
9.5.4 PARTICIPANTS 372
FIGURE 44 OPHTHALMIC EQUIPMENT MARKET: COMPETITIVE LEADERSHIP MAPPING FOR KEY PLAYERS (2022) 373
9.5.5 COMPANY FOOTPRINT 374
TABLE 383 OVERALL COMPANY FOOTPRINT: OPHTHALMIC EQUIPMENT MARKET 374
TABLE 384 PRODUCT FOOTPRINT: OPHTHALMIC EQUIPMENT MARKET (2022) 375
TABLE 385 END USER FOOTPRINT: OPHTHALMIC EQUIPMENT MARKET (2022) 376
TABLE 386 REGIONAL FOOTPRINT: OPHTHALMIC EQUIPMENT MARKET (2022) 377
9.6 COMPETITIVE LEADERSHIP MAPPING: START-UPS 378
9.6.1 PROGRESSIVE COMPANIES 378
9.6.2 DYNAMIC COMPANIES 378
9.6.3 STARTING BLOCKS 378
9.6.4 RESPONSIVE COMPANIES 378
FIGURE 45 OPHTHALMIC EQUIPMENT MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2022) 379
9.6.5 COMPETITIVE BENCHMARKING FOR START-UPS 380
9.7 COMPETITIVE SCENARIOS AND TRENDS 380
9.7.1 PRODUCT LAUNCHES 380
TABLE 387 OPHTHALMIC EQUIPMENT MARKET: PRODUCT LAUNCHES, 2020–2023 380
9.7.2 DEALS 381
TABLE 388 OPHTHALMIC EQUIPMENT MARKET: DEALS, 2020–2023 381
9.7.3 OTHER DEVELOPMENTS 382
TABLE 389 OPHTHALMIC EQUIPMENT MARKET: OTHER DEVELOPMENTS, 2020–2023 382
10 COMPANY PROFILES 383
10.1 KEY PLAYERS 383
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
10.1.1 BAUSCH HEALTH COMPANIES INC. 383
TABLE 390 BAUSCH HEALTH COMPANIES INC.: BUSINESS OVERVIEW 383
FIGURE 46 BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT (2022) 384
10.1.2 ALCON 388
TABLE 391 ALCON: BUSINESS OVERVIEW 388
FIGURE 47 ALCON: COMPANY SNAPSHOT (2022) 389
10.1.3 CARL ZEISS MEDITEC AG 393
TABLE 392 CARL ZEISS MEDITEC AG: BUSINESS OVERVIEW 393
FIGURE 48 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2022) 394
10.1.4 JOHNSON & JOHNSON 398
TABLE 393 JOHNSON & JOHNSON: BUSINESS OVERVIEW 398
FIGURE 49 JOHNSON & JOHNSON VISION CARE: COMPANY SNAPSHOT (2022) 399
10.1.5 HOYA CORPORATION 404
TABLE 394 HOYA CORPORATION: BUSINESS OVERVIEW 404
FIGURE 50 HOYA CORPORATION: COMPANY SNAPSHOT (2022) 405
10.1.6 THE COOPER COMPANIES, INC. 409
TABLE 395 THE COOPER COMPANIES, INC.: BUSINESS OVERVIEW 409
FIGURE 51 THE COOPER COMPANIES, INC. (COOPERVISION): COMPANY SNAPSHOT (2022) 410
10.1.7 ESSILORLUXOTTICA 413
TABLE 396 ESSILORLUXOTTICA: BUSINESS OVERVIEW 413
FIGURE 52 ESSILORLUXOTTICA: COMPANY SNAPSHOT (2022) 414
10.1.8 CANON 418
TABLE 397 CANON: BUSINESS OVERVIEW 418
FIGURE 53 CANON: COMPANY SNAPSHOT (2022) 419
10.1.9 GLAUKOS CORPORATION 420
TABLE 398 GLAUKOS CORPORATION: BUSINESS OVERVIEW 420
FIGURE 54 GLAUKOS CORPORATION: COMPANY SNAPSHOT (2022) 421
10.1.10 NIDEK CO., LTD. 424
TABLE 399 NIDEK: BUSINESS OVERVIEW 424
10.1.11 TOPCON 428
TABLE 400 TOPCON: BUSINESS OVERVIEW 428
FIGURE 55 TOPCON: COMPANY SNAPSHOT (2022) 429
10.1.12 ZEIMER OPHTHALMIC SYSTEMS 432
TABLE 401 ZEIMER OPHTHALMIC SYSTEMS: BUSINESS OVERVIEW 432
10.1.13 STAAR SURGICAL 434
TABLE 402 STAAR SURGICAL: BUSINESS OVERVIEW 434
FIGURE 56 STAAR SURGICAL: COMPANY SNAPSHOT (2022) 435
10.1.14 HAAG-STREIT 437
TABLE 403 HAAG-STREIT: BUSINESS OVERVIEW 437
10.1.15 QUANTEL MEDICAL 440
TABLE 404 QUANTEL MEDICAL: BUSINESS OVERVIEW 440
10.1.16 COBURN TECHNOLOGIES, INC. 442
TABLE 405 COBURN TECHNOLOGIES, INC.: BUSINESS OVERVIEW 442
10.1.17 FCI OPHTHALMICS 444
TABLE 406 FCI OPHTHALMICS: BUSINESS OVERVIEW 444
10.1.18 MATRONIX INDIA CORPORATION 447
TABLE 407 MATRONIX INDIA CORPORATION: BUSINESS OVERVIEW 447
10.1.19 HEINE OPTOTECHNIK 449
TABLE 408 HEINE OPTOTECHNIK: BUSINESS OVERVIEW 449
10.1.20 VISIONIX 451
TABLE 409 VISIONIX: BUSINESS OVERVIEW 451
10.1.21 NEO VISION 454
TABLE 410 NEO VISION: BUSINESS OVERVIEW 454
10.1.22 BVI 455
TABLE 411 BVI: BUSINESS OVERVIEW 455
10.1.23 DUTCH OPHTHALMIC RESEARCH CENTRE 456
TABLE 412 DORC: BUSINESS OVERVIEW 456
10.1.24 CORZA 457
TABLE 413 CORZA MEDICAL: BUSINESS OVERVIEW 457
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
10.2 OTHER PLAYERS 459
10.2.1 CLEAR LAB 459
10.2.2 APPASAMY ASSOCIATES 460
10.2.3 OPHTEC BV 461
10.2.4 LUMENIS 462
10.2.5 INTUVISION LABS 463
11 APPENDIX 464
11.1 DISCUSSION GUIDE 464
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 470
11.3 CUSTOMIZATION OPTIONS 472
11.4 RELATED REPORTS 473
11.5 AUTHOR DETAILS 474

★調査レポート[世界の眼科機器市場（～2029年）：機器別（外科（膜硝子体、IOL、OVD、コンタクトレンズ、RGPレンズ、バックフラッシュ）、診断・モニタリング（OCT、オートレフラクター、角膜計、眼圧計、検眼鏡、OVD））、エンドユーザー別] (コード：MD2334-24)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の眼科機器市場（～2029年）：機器別（外科（膜硝子体、IOL、OVD、コンタクトレンズ、RGPレンズ、バックフラッシュ）、診断・モニタリング（OCT、オートレフラクター、角膜計、眼圧計、検眼鏡、OVD））、エンドユーザー別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 眼科＆検眼機器の世界市場2023-2029：OCT機器、眼底カメラ、細隙灯、眼圧計、手術用顕微鏡、オートレフラクター・ケラトメーター、検眼鏡・網膜鏡、その他
  • 世界の耐久型医療機器（DME）市場予測2023年-2028年：製品別（パーソナルモビリティデバイス、バスルームセーフティデバイス・医療用家具、モニタリング・治療デバイス）、エンドユーザー別（病院、介護施設、在宅医療、その他）、地域別
  • 世界のペーパー診断市場（2023-2030）：キット種類別（ラテラルフローアッセイ、ペーパーベースマイクロフルイディクス）、デバイス種類別（診断、モニタリング）、用途別、エンドユーザー別、地域別
  • 世界のスポーツ用アイウェア市場2021年-2027年：製品タイプ別（度付きメガネ、サングラス、コンタクトレンズ）、エンドユーザー別（男性、女性）、販売形態別（小売店、オンラインショップ）
  • 世界の耐久性医療機器（DME）市場2023-2033：製品別（モニタリング＆治療機器、個人用移動機器、浴室安全機器、医療用家具、失禁パッド、乳房ポンプ、カテーテル、消耗品＆付属品）、エンドユーザー別（病院、介護施設、在宅医療、外来手術センター）、地域別
  • 世界のデジタルバイオマーカー市場2023年-2032年：種類別（ウェアラブル、モバイルアプリケーション、その他）、用途別（心血管疾患、糖尿病、神経疾患、呼吸器疾患、その他）、臨床別（モニタリング、診断、予後）、エンドユーザー別（医療提供者、医療消費者、その他）
  • 世界の医療用センサー市場2023年-2032年：種類別（流量センサー、画像センサー、温度センサー、圧力センサー、その他の種類）、用途別（診断、治療、モニタリング、ウェルネス・フィットネス、その他）、技術別（ウェアラブルセンサー、インプラントセンサー、ワイヤレス、その他）、エンドユーザー別（病院、診療所、在宅医療、その他）

    • ◆H&Iグローバルリサーチのお客様（例）◆